MedTrace Logo

Zero Ischemia Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma With T1a Stage

NCT01838720 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2014-08-13

No results posted yet for this study

Summary

To evaluate the feasibility and efficiency of zero ischemia laparoscopic radio frequency ablation assisted enucleation of T1a renal cell carcinoma in comparison with the conventional laparoscopic partial nephrectomy.

Conditions

Interventions

PROCEDURE

zero ischemia laparoscopic RFA assisted TE

PROCEDURE

ischemia

conventional laparoscopic partial nephrectomy

Sponsors & Collaborators

  • National Natural Science Foundation of China

    collaborator OTHER_GOV

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Yiran Huang, M.D. · RenJi Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01838720 on ClinicalTrials.gov